Chronic hepatitis C course at elderly and therapeutic approach

QR Code

Chronic hepatitis C course at elderly and therapeutic approach

The aim of review. To discuss features of course of chronic hepatitis C virus infection at elderly, efficacy and safety of antiviral treatment of patients of this age group.Original positions. In every day clinical practice elderly patients with chronic hepatitis C are extremely rarely considered as...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Mayevskaya, M. A. Morozova
Format:	Article
Language:	Russian
Published:	Gastro LLC 2011-02-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	elderly age chronic hepatitis c liver fibrosis antiviral therapy
Online Access:	https://www.gastro-j.ru/jour/article/view/1363
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C
by: I. A. Narkevich, et al.
Published: (2024-02-01)

Comorbidity and multimorbidity in patients with chronic hepatitis C
by: Ya. E. Saranskaya, et al.
Published: (2022-10-01)

Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
by: N. S. Zhevnerova, et al.
Published: (2016-12-01)

Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

TREATMENT OF HEPATITIS C WITHOUT INTERFERON IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2015-10-01)

Adverse Effects of Combined Antiviral Therapy of Chronic Hepatitis C Virus and Methods for It’s Correction
by: Y. M. Ambalov, et al.
Published: (2011-09-01)

Liver CT Perfusion Imaging as a Non-Invasive Method for Assessing Hemodynamics of the Hepatic Parenchyma in Patients with Fibrosis and Cirrhosis as a Result of Chronic Viral Hepatitis C
by: G. A. Stashuk, et al.
Published: (2022-02-01)

Modern modes of chronic hepatitis C treatment
by: V. T. Ivashkin, et al.
Published: (2012-02-01)

Effectiveness and safety of narlaprevir in real clinical practice of chronic hepatitis C
by: V. V. Basina, et al.
Published: (2019-12-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Chronic Hepatitis B In Elite Athletes
by: T. H. Nguyen, et al.
Published: (2025-03-01)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)

Herbal medications in the treatment of hepatitis C
by: V. T. Ivashkin, et al.
Published: (2009-06-01)

The prognostic value of ferritinemia level in patients with chronic hepatitis C
by: N. C. Sargsyants, et al.
Published: (2013-07-01)

LIPID METABOLISM DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS C
by: L. I. Tkachenko, et al.
Published: (2015-12-01)

CYTOKINES, CHEMOKINES AND GROWTH FACTORS ASSOCIATED WITH CHRONIC VIRAL HEPATITIS C
by: Natalia A. Arsentieva, et al.
Published: (2019-08-01)

Application of dicarbamin in treatment of patients by a chronic hepatitis C
by: D. Yu. Konstantinov, et al.
Published: (2011-09-01)

CHANGES PROTEIN SPECTRUM OF BLOOD PLASMA, WHICH DEVELOP IN PATIENTS WITH CHRONIC HEPATITIS C AFTER AUTOHAEMOTHERAPY
by: D. V. Dontcov, et al.
Published: (2015-12-01)

Betaleukin in therapy of chronic hepatitis C
by: E. S. Romanova, et al.
Published: (2014-10-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)

Change of the indices of the cytokine status in patients with chronic combined hepatitis B+C in a process of antiviral therapy
by: O. L. Sobolevskaya
Published: (2014-09-01)

ACTUAL PRINCIPLES OF THERAPY CHRONIC HEPATITIS OF VARIOUS ETIOLOGIES
by: I. V. Semenova, et al.
Published: (2015-12-01)

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Modern modes of chronic hepatitis B treatment in daily clinical practice
by: M. V. Mayevskaya, et al.
Published: (2014-11-01)

Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-12-01)

POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01)

Cytokine profiling of plasma in patients with viral hepatitis C
by: N. A. Arsentieva, et al.
Published: (2024-11-01)

Cirrhosis of the liver and hepatocellular carcinoma in the outcome of chronic hepatitis C: a case report
by: V. V. Makashova, et al.
Published: (2023-04-01)

Adiponectin level and severity of liver fibrosis in patients chronic hepatitis C with metabolic syndrome
by: A. F. Novikova, et al.
Published: (2018-07-01)

The level of galectin-3 in the blood serum of patients with chronic hepatitis C
by: V. A. Kovalevа, et al.
Published: (2016-07-01)

Effects of antiviral therapy on reducing the risk of metabolic syndrome in patients with chronic hepatitis C
by: A. F. Novikova, et al.
Published: (2023-07-01)

Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
by: M. Sh. Khubutia, et al.
Published: (2016-01-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Minimization of Endogenous Intoxication Syndrome by Individual Choice of Drugs for Therapy of Chronic Hepatitis
by: D. K. Vasilyeva, et al.
Published: (2020-05-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

Clinical and immunomorphological predictors of the adverse course of chronic hepatitis C
by: I. A. Karabak, et al.
Published: (2020-06-01)

The importance of single-nucleotide gene polymorphisms in the formation of liver cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C
by: I. V. Mannanova, et al.
Published: (2024-06-01)

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study
by: Shou-Wu Lee, et al.
Published: (2025-07-01)

The efficacy and safety of antiviral drugs of direct action in liver recipients with recurrence of chronic hepatitis C genotype 1 after transplantation
by: О. M. Tsiroulnikova, et al.
Published: (2019-01-01)